Venus Concept (VERO) Competitors

$0.70
+0.02 (+2.33%)
(As of 01:16 PM ET)

VERO vs. STSS, AFIB, AEMD, TMDIF, IONM, GMVDF, TNON, INVO, QNRX, and DYNT

Should you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include Sharps Technology (STSS), Acutus Medical (AFIB), Aethlon Medical (AEMD), Titan Medical (TMDIF), Assure (IONM), G Medical Innovations (GMVDF), Tenon Medical (TNON), INVO Bioscience (INVO), Quoin Pharmaceuticals (QNRX), and Dynatronics (DYNT). These companies are all part of the "surgical & medical instruments" industry.

Venus Concept vs.

Venus Concept (NASDAQ:VERO) and Sharps Technology (NASDAQ:STSS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends.

Venus Concept has a beta of 0.65, indicating that its stock price is 35% less volatile than the S&P 500. Comparatively, Sharps Technology has a beta of 1.13, indicating that its stock price is 13% more volatile than the S&P 500.

Sharps Technology has a net margin of 0.00% compared to Venus Concept's net margin of -48.79%. Venus Concept's return on equity of 0.00% beat Sharps Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Venus Concept-48.79% N/A -36.21%
Sharps Technology N/A -103.10%-76.46%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Venus Concept
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Sharps Technology
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

87.4% of Venus Concept shares are owned by institutional investors. Comparatively, 17.2% of Sharps Technology shares are owned by institutional investors. 51.4% of Venus Concept shares are owned by insiders. Comparatively, 14.1% of Sharps Technology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Venus Concept and Venus Concept both had 1 articles in the media. Venus Concept's average media sentiment score of 0.00 equaled Sharps Technology'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Venus Concept
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Sharps Technology
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Sharps Technology has lower revenue, but higher earnings than Venus Concept.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Venus Concept$76.35M0.06-$37.25M-$6.85-0.10
Sharps TechnologyN/AN/A-$9.84MN/AN/A

Venus Concept received 33 more outperform votes than Sharps Technology when rated by MarketBeat users. However, 100.00% of users gave Sharps Technology an outperform vote while only 65.38% of users gave Venus Concept an outperform vote.

CompanyUnderperformOutperform
Venus ConceptOutperform Votes
34
65.38%
Underperform Votes
18
34.62%
Sharps TechnologyOutperform Votes
1
100.00%
Underperform Votes
No Votes

Summary

Venus Concept beats Sharps Technology on 6 of the 10 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VERO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERO vs. The Competition

MetricVenus ConceptSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$4.33M$3.86B$4.99B$7.78B
Dividend YieldN/A2.15%2.84%3.96%
P/E Ratio-0.1020.64186.5419.45
Price / Sales0.0663.182,414.2879.90
Price / CashN/A45.3233.5428.62
Price / Book-0.284.224.934.39
Net Income-$37.25M$4.65M$105.35M$217.65M
7 Day Performance-1.94%-1.44%0.39%1.04%
1 Month Performance-1.12%-5.38%-3.59%-2.66%
1 Year Performance-82.28%8.26%3.35%9.46%

Venus Concept Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STSS
Sharps Technology
0 of 5 stars
$0.27
+3.9%
N/A-68.7%$4.20MN/A0.0057Gap Down
AFIB
Acutus Medical
0 of 5 stars
$0.15
-6.3%
N/A-90.4%$4.46M$7.16M-0.12230Gap Down
AEMD
Aethlon Medical
1.351 of 5 stars
$1.40
+2.2%
$10.00
+614.3%
-64.8%$3.67M$570,000.00-0.2815Analyst Forecast
TMDIF
Titan Medical
0 of 5 stars
$0.04
flat
N/A-70.5%$5.01M$17.63M1.1033
IONM
Assure
1.3658 of 5 stars
$0.49
-14.1%
$4.00
+719.7%
-80.9%$3.28M$10.98M0.00127Gap Up
GMVDF
G Medical Innovations
0 of 5 stars
$0.01
flat
N/AN/A$3.15M$4.42M0.0084Gap Down
High Trading Volume
TNON
Tenon Medical
1.8274 of 5 stars
$0.75
+1.4%
$3.00
+299.8%
-54.0%$2.80M$2.93M-0.0821Upcoming Earnings
INVO
INVO Bioscience
0 of 5 stars
$1.00
-5.7%
N/A-86.4%$2.74M$3.02M-0.0815Gap Up
QNRX
Quoin Pharmaceuticals
1.1836 of 5 stars
$0.71
+2.9%
$4.00
+465.0%
-88.5%$2.61MN/A-0.074News Coverage
Gap Up
DYNT
Dynatronics
0.8251 of 5 stars
$0.51
-3.8%
$3.80
+643.6%
-66.0%$2.49M$40.61M-0.37154News Coverage
Gap Up

Related Companies and Tools

This page (NASDAQ:VERO) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners